Perrigo Company plc (PRGO)
NYSE: PRGO · Real-Time Price · USD
14.92
+0.65 (4.56%)
At close: Sep 4, 2026, 4:00 PM EDT
14.95
+0.03 (0.20%)
After-hours: Sep 4, 2026, 7:30 PM EDT
Perrigo Company Revenue
Perrigo Company had revenue of $1.02B in the quarter ending June 27, 2026, a decrease of -3.17%. This brings the company's revenue in the last twelve months to $4.14B, down -10.94% year-over-year. In the year 2025, Perrigo Company had annual revenue of $4.25B, down -2.75%.
Revenue (ttm)
$4.14B
Revenue Growth
-10.94%
P/S Ratio
0.50
Revenue / Employee
$511,716
Employees
8,100
Market Cap
2.07B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 4.25B | -120.30M | -2.75% |
| Dec 31, 2024 | 4.37B | -282.20M | -6.06% |
| Dec 31, 2023 | 4.66B | 204.00M | 4.58% |
| Dec 31, 2022 | 4.45B | 312.90M | 7.56% |
| Dec 31, 2021 | 4.14B | 50.50M | 1.24% |
| Dec 31, 2020 | 4.09B | 218.30M | 5.64% |
| Dec 31, 2019 | 3.87B | -861.80M | -18.21% |
| Dec 31, 2018 | 4.73B | -214.50M | -4.34% |
| Dec 31, 2017 | 4.95B | -334.40M | -6.33% |
| Dec 31, 2016 | 5.28B | 2.65B | 100.62% |
| Dec 31, 2015 | 2.63B | -1.59B | -37.73% |
| Jun 27, 2015 | 4.23B | 313.00M | 8.00% |
| Jun 28, 2014 | 3.91B | 374.30M | 10.57% |
| Jun 29, 2013 | 3.54B | 366.60M | 11.55% |
| Jun 30, 2012 | 3.17B | 418.20M | 15.18% |
| Jun 25, 2011 | 2.76B | 486.85M | 21.46% |
| Jun 26, 2010 | 2.27B | 262.56M | 13.09% |
| Jun 27, 2009 | 2.01B | 275.67M | 15.94% |
| Jun 28, 2008 | 1.73B | 361.57M | 26.42% |
| Jun 30, 2007 | 1.37B | 1.53M | 0.11% |
| Jul 1, 2006 | 1.37B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Bausch Health Companies | 10.85B |
| Phibro Animal Health | 1.52B |
| Trulieve Cannabis | 1.14B |
| Prestige Consumer Healthcare | 1.10B |
| ANI Pharmaceuticals | 978.38M |
| BioCryst Pharmaceuticals | 940.61M |
| Supernus Pharmaceuticals | 830.44M |
| HUTCHMED (China) | 549.12M |
PRGO News
- 9 days ago - Perrigo to Attend the Barclays Global Consumer Conference - PRNewsWire
- 24 days ago - Perrigo Company Transcript: Canaccord Genuity's 46th Annual Growth Conference - Transcripts
- 24 days ago - Perrigo Company Slides: Canaccord Genuity's 46th Annual Growth Conference - Filings
- 4 weeks ago - Perrigo Company Earnings Call Transcript: Q2 2026 - Transcripts
- 4 weeks ago - Perrigo Company Earnings release: Q2 2026 - Filings
- 4 weeks ago - Perrigo Company Slides: Q2 2026 - Filings
- 4 weeks ago - Perrigo Company Quarterly report: Q2 2026 - Filings
- 4 weeks ago - Perrigo Reports Second Quarter 2026 Financial Results From Continuing Operations - PRNewsWire